Ontozry Treatment Initiation Pack 12.5 mg tablets and 25 mg film-coated tablets
Manufacturer/MA Holder:
Angelini Pharma UK-I Limited
MA Number:
PLGB 56215/0007
Drug Safety Category
Unclassified
Active Ingredient
Cenobamate
Formulation
Tablet & Film Coated Tablet
Strength
12.5mg & 25mg
Licensed for use with feeding tube
No
Confirmed as carbohydrate free
No
Length/Diameter
6.3mm
SPC URL
Open SPC
Excipients of concern
Lactose
39.7mg in the 12.5mg tablet
Lactose
79.3mg in the 25mg tablet